<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37555661</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Cleavage of 14-3-3ε by the enteroviral 3C protease dampens RIG-I-mediated antiviral signaling.</ArticleTitle><Pagination><StartPage>e0060423</StartPage><MedlinePgn>e0060423</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00604-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00604-23</ELocationID><Abstract><AbstractText>Viruses have evolved diverse strategies to evade the host innate immune response and promote infection. The retinoic acid-inducible gene I (RIG-I)-like receptors RIG-I and MDA5 are antiviral factors that sense viral RNA and trigger downstream signal via mitochondrial antiviral-signaling protein (MAVS) to activate type I interferon expression. 14-3-3ε is a key component of the RIG-I translocon complex that interacts with MAVS at the mitochondrial membrane; however, the exact role of 14-3-3ε in this pathway is not well understood. In this study, we demonstrate that 14-3-3ε is a direct substrate of both the poliovirus and coxsackievirus B3 (CVB3) 3C proteases (3C<sup>pro</sup>) and that it is cleaved at Q236↓G237, resulting in the generation of N- and C-terminal fragments of 27.0 and 2.1 kDa, respectively. While the exogenous expression of wild-type 14-3-3ε enhances <i>IFNB</i> mRNA production during poly(I:C) stimulation, expression of the truncated N-terminal fragment does not. The N-terminal 14-3-3ε fragment does not interact with RIG-I in co-immunoprecipitation assays, nor can it facilitate RIG-I translocation to the mitochondria. Probing the intrinsically disordered C-terminal region identifies key residues responsible for the interaction between 14-3-3ε and RIG-I. Finally, overexpression of the N-terminal fragment promotes CVB3 infection in mammalian cells. The strategic enterovirus 3C<sup>pro</sup>-mediated cleavage of 14-3-3ε antagonizes RIG-I signaling by disrupting critical interactions within the RIG-I translocon complex, thus contributing to evasion of the host antiviral response. IMPORTANCE Host antiviral factors work to sense virus infection through various mechanisms, including a complex signaling pathway known as the retinoic acid-inducible gene I (RIG-I)-like receptor pathway. This pathway drives the production of antiviral molecules known as interferons, which are necessary to establish an antiviral state in the cellular environment. Key to this antiviral signaling pathway is the small chaperone protein 14-3-3ε, which facilitates the delivery of a viral sensor protein, RIG-I, to the mitochondria. In this study, we show that the enteroviral 3C protease cleaves 14-3-3ε during infection, rendering it incapable of facilitating this antiviral response. We also find that the resulting N-terminal cleavage fragment dampens RIG-I signaling and promotes virus infection. Our findings reveal a novel viral strategy that restricts the antiviral host response and provides insights into the mechanisms underlying 14-3-3ε function in RIG-I antiviral signaling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Daniel D T</ForeName><Initials>DDT</Initials><Identifier Source="ORCID">0000-0002-5063-738X</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Sciences Institute, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlok</LastName><ForeName>Marli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Sciences Institute, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbari Bani</LastName><ForeName>Dorssa</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Sciences Institute, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Brenna N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Sciences Institute, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Smith Laboratories, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamud</LastName><ForeName>Yasir</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foster</LastName><ForeName>Leonard J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Michael Smith Laboratories, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Overall</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Sciences Institute, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oral Biological and Medical Sciences, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Blood Research, University of British Columbia , Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jan</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0523-8467</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life Sciences Institute, University of British Columbia , Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PJT-156351</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT-173318</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>5688UTC01R</RegistryNumber><NameOfSubstance UI="D014212">Tretinoin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010849" MajorTopicYN="Y">Picornaviridae</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014212" MajorTopicYN="N">Tretinoin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RIG-I</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">innate immune response</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">protease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>12</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>9</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37555661</ArticleId><ArticleId IdType="pmc">PMC10506458</ArticleId><ArticleId IdType="doi">10.1128/jvi.00604-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iwasaki A. 2012. A virological view of innate immune recognition. Annu Rev Microbiol 66:177–196. doi:10.1146/annurev-micro-092611-150203</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-micro-092611-150203</ArticleId><ArticleId IdType="pmc">PMC3549330</ArticleId><ArticleId IdType="pubmed">22994491</ArticleId></ArticleIdList></Reference><Reference><Citation>Beachboard DC, Horner SM. 2016. Innate immune evasion strategies of DNA and RNA viruses. Curr Opin Microbiol 32:113–119. doi:10.1016/j.mib.2016.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2016.05.015</ArticleId><ArticleId IdType="pmc">PMC4983539</ArticleId><ArticleId IdType="pubmed">27288760</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagdeo JM, Dufour A, Klein T, Solis N, Kleifeld O, Kizhakkedathu J, Luo H, Overall CM, Jan E. 2018. N-Terminomics TAILS identifies host cell substrates of poliovirus and coxsackievirus B3 3C proteinases that modulate virus infection. J Virol 92:e02211-17. doi:10.1128/JVI.02211-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02211-17</ArticleId><ArticleId IdType="pmc">PMC5874412</ArticleId><ArticleId IdType="pubmed">29437971</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagdeo JM, Dufour A, Fung G, Luo H, Kleifeld O, Overall CM, Jan E. 2015. Heterogeneous nuclear ribonucleoprotein M facilitates Enterovirus infection. Edited by Kirkegaard K.. J Virol 89:7064–7078. doi:10.1128/JVI.02977-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02977-14</ArticleId><ArticleId IdType="pmc">PMC4473559</ArticleId><ArticleId IdType="pubmed">25926642</ArticleId></ArticleIdList></Reference><Reference><Citation>Pablos I, Machado Y, de Jesus HCR, Mohamud Y, Kappelhoff R, Lindskog C, Vlok M, Bell PA, Butler GS, Grin PM, Cao QT, Nguyen JP, Solis N, Abbina S, Rut W, Vederas JC, Szekely L, Szakos A, Drag M, Kizhakkedathu JN, Mossman K, Hirota JA, Jan E, Luo H, Banerjee A, Overall CM. 2021. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. Cell Rep 37:109892. doi:10.1016/j.celrep.2021.109892</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109892</ArticleId><ArticleId IdType="pmc">PMC8501228</ArticleId><ArticleId IdType="pubmed">34672947</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel J, Gack MU. 2020. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol 20:537–551. doi:10.1038/s41577-020-0288-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0288-3</ArticleId><ArticleId IdType="pmc">PMC7094958</ArticleId><ArticleId IdType="pubmed">32203325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann G. 2017. Nucleic acid immunity. Adv Immunol 133:121–169. doi:10.1016/bs.ai.2016.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ai.2016.11.001</ArticleId><ArticleId IdType="pmc">PMC7112058</ArticleId><ArticleId IdType="pubmed">28215278</ArticleId></ArticleIdList></Reference><Reference><Citation>Goubau D, Deddouche S, Reis e Sousa C. 2013. Cytosolic sensing of viruses. Immunity 38:855–869. doi:10.1016/j.immuni.2013.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.05.007</ArticleId><ArticleId IdType="pmc">PMC7111113</ArticleId><ArticleId IdType="pubmed">23706667</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423–435. doi:10.1016/j.cell.2011.09.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.09.039</ArticleId><ArticleId IdType="pubmed">22000019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack MU, Shin YC, Joo C-H, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916–920. doi:10.1038/nature05732</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05732</ArticleId><ArticleId IdType="pubmed">17392790</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HM, Loo Y-M, Horner SM, Zornetzer GA, Katze MG, Gale M. 2012. The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11:528–537. doi:10.1016/j.chom.2012.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.04.006</ArticleId><ArticleId IdType="pmc">PMC3358705</ArticleId><ArticleId IdType="pubmed">22607805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Hur S. 2015. How RIG-I like receptors activate MAVS. Curr Opin Virol 12:91–98. doi:10.1016/j.coviro.2015.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2015.04.004</ArticleId><ArticleId IdType="pmc">PMC4470786</ArticleId><ArticleId IdType="pubmed">25942693</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo Y-M, Gale M. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680–692. doi:10.1016/j.immuni.2011.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.003</ArticleId><ArticleId IdType="pmc">PMC3177755</ArticleId><ArticleId IdType="pubmed">21616437</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum A, García-Sastre A. 2011. Differential recognition of viral RNA by RIG-I. Virulence 2:166–169. doi:10.4161/viru.2.2.15481</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.2.2.15481</ArticleId><ArticleId IdType="pmc">PMC3100765</ArticleId><ArticleId IdType="pubmed">21422808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J-P, Fan Y-K, Liu HM. 2019. The 14-3-3η chaperone protein promotes antiviral innate immunity via facilitating MDA5 oligomerization and intracellular redistribution. PLoS Pathog 15:e1007582. doi:10.1371/journal.ppat.1007582</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007582</ArticleId><ArticleId IdType="pmc">PMC6386420</ArticleId><ArticleId IdType="pubmed">30742689</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennington KL, Chan TY, Torres MP, Andersen JL. 2018. The dynamic and stress-adaptive signaling Hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions. Oncogene 37:5587–5604. doi:10.1038/s41388-018-0348-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-018-0348-3</ArticleId><ArticleId IdType="pmc">PMC6193947</ArticleId><ArticleId IdType="pubmed">29915393</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalal SN, Yaffe MB, DeCaprio JA. 2004. 14-3-3 family members act coordinately to regulate mitotic progression. Cell Cycle 3:672–677.</Citation><ArticleIdList><ArticleId IdType="pubmed">15107609</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YK, Gack MU. 2016. A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol 17:523–530. doi:10.1038/ni.3393</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3393</ArticleId><ArticleId IdType="pmc">PMC4837045</ArticleId><ArticleId IdType="pubmed">26998762</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Ma Y, Voss K, van Gent M, Chan YK, Gack MU, Gale M, He B, Pellett PE. 2021. The herpesvirus accessory protein γ134.5 facilitates viral replication by disabling mitochondrial translocation of RIG-I. PLoS Pathog 17:e1009446. doi:10.1371/journal.ppat.1009446</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009446</ArticleId><ArticleId IdType="pmc">PMC7996975</ArticleId><ArticleId IdType="pubmed">33770145</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedl W, Acharya D, Lee J-H, Liu G, Serman T, Chiang C, Chan YK, Diamond MS, Gack MU. 2019. Zika virus NS3 mimics a cellular 14-3-3-binding motif to antagonize RIG-I- and MDA5-mediated innate immunity. Cell Host Microbe 26:493–503. doi:10.1016/j.chom.2019.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.09.012</ArticleId><ArticleId IdType="pmc">PMC6922055</ArticleId><ArticleId IdType="pubmed">31600501</ArticleId></ArticleIdList></Reference><Reference><Citation>Won J, Kim DY, La M, Kim D, Meadows GG, Joe CO. 2003. Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis. J Biol Chem 278:19347–19351. doi:10.1074/jbc.M213098200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M213098200</ArticleId><ArticleId IdType="pubmed">12657644</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C, Crowther S, Stafford MJ, Campbell DG, Toth R, MacKintosh C. 2010. Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J 427:69–78. doi:10.1042/BJ20091834</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20091834</ArticleId><ArticleId IdType="pmc">PMC2860806</ArticleId><ArticleId IdType="pubmed">20141511</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridges D, Moorhead GBG. 2005. 14-3-3 proteins: a number of functions for a numbered protein. science’s STKE: signal transduction knowledge environment. American Association for the Advancement of Science:re10–re10. doi:10.1126/stke.2962005re10</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/stke.2962005re10</ArticleId><ArticleId IdType="pubmed">16091624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Lee WH, Sobott F, Papagrigoriou E, Robinson CV, Grossmann JG, Sundström M, Doyle DA, Elkins JM. 2006. Structural basis for protein-protein interactions in the 14-3-3 protein family. Proc Natl Acad Sci U S A 103:17237–17242. doi:10.1073/pnas.0605779103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605779103</ArticleId><ArticleId IdType="pmc">PMC1859916</ArticleId><ArticleId IdType="pubmed">17085597</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal D, Maier S, Mastromarco GJ, Qian WW, Nabeel-Shah S, Lee H, Moore G, Lacoste J, Larsen B, Lin Z-Y, Selvabaskaran A, Liu K, Smibert C, Zhang Z, Greenblatt J, Peng J, Lee HO, Gingras A-C, Taipale M. 2023. A central chaperone-like role for 14-3-3 proteins in human cells. Mol Cell 83:974–993. doi:10.1016/j.molcel.2023.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2023.02.018</ArticleId><ArticleId IdType="pubmed">36931259</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider DL, Park M, Murphy KA, Beachboard DC, Horner SM. 2022. Signaling from the RNA sensor RIG-I is regulated by ufmylation. Proc Natl Acad Sci U S A 119:e2119531119. doi:10.1073/pnas.2119531119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2119531119</ArticleId><ArticleId IdType="pmc">PMC9169834</ArticleId><ArticleId IdType="pubmed">35394863</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam E-H, Liu Y-C, Woung C-H, Liu HM, Wu G-H, Wu C-C, Kuo R-L. 2021. Role of the chaperone protein 14-3-3ε in the regulation of influenza A virus-activated beta interferon. J Virol 95:e0023121. doi:10.1128/JVI.00231-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00231-21</ArticleId><ArticleId IdType="pmc">PMC8475545</ArticleId><ArticleId IdType="pubmed">34379499</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Ylä-Anttila P, Sandalova T, Sun R, Achour A, Masucci MG. 2019. 14-3-3 scaffold proteins mediate the inactivation of TRIM25 and inhibition of the type I interferon response by herpesvirus deconjugases. PLoS Pathog 15:e1008146. doi:10.1371/journal.ppat.1008146</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008146</ArticleId><ArticleId IdType="pmc">PMC6874091</ArticleId><ArticleId IdType="pubmed">31710640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleifeld O, Doucet A, Prudova A, auf dem Keller U, Gioia M, Kizhakkedathu JN, Overall CM. 2011. Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates. Nat Protoc 6:1578–1611. doi:10.1038/nprot.2011.382</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2011.382</ArticleId><ArticleId IdType="pubmed">21959240</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleifeld O, Doucet A, auf dem Keller U, Prudova A, Schilling O, Kainthan RK, Starr AE, Foster LJ, Kizhakkedathu JN, Overall CM. 2010. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 28:281–288. doi:10.1038/nbt.1611</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1611</ArticleId><ArticleId IdType="pubmed">20208520</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanecak R, Semler BL, Anderson CW, Wimmer E. 1982. Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7C inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A 79:3973–3977. doi:10.1073/pnas.79.13.3973</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.79.13.3973</ArticleId><ArticleId IdType="pmc">PMC346558</ArticleId><ArticleId IdType="pubmed">6287457</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel B, Autret A, Brisac C, Martin-Latil S, Mousson L, Pelletier I, Estaquier J, Colbere-Garapin F. 2009. Apoptotic signaling cascades operating in poliovirus-infected cells. Front Biosci (Landmark Ed) 14:2181–2192. doi:10.2741/3370</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3370</ArticleId><ArticleId IdType="pubmed">19273192</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolskaya EA, Romanova LI, Kolesnikova MS, Ivannikova TA, Smirnova EA, Raikhlin NT, Agol VI. 1995. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol 69:1181–1189. doi:10.1128/JVI.69.2.1181-1189.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.2.1181-1189.1995</ArticleId><ArticleId IdType="pmc">PMC188691</ArticleId><ArticleId IdType="pubmed">7529330</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulet M-L, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, Kalinke U, Qureshi S, Lamarre A, Haddad EK, Sekaly RP, Peri S, Balachandran S, Lin R, Hiscott J. 2013. Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity. PLoS Pathog 9:e1003298. doi:10.1371/journal.ppat.1003298</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003298</ArticleId><ArticleId IdType="pmc">PMC3635991</ArticleId><ArticleId IdType="pubmed">23633948</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M. 1999. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274:22932–22940. doi:10.1074/jbc.274.33.22932</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.33.22932</ArticleId><ArticleId IdType="pubmed">10438458</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao S-M, Maniatis T. 2003. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496. doi:10.1038/ni921</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardino AK, Smerdon SJ, Yaffe MB. 2006. Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms. Semin Cancer Biol 16:173–182. doi:10.1016/j.semcancer.2006.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2006.03.007</ArticleId><ArticleId IdType="pubmed">16678437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilker EW, Grant RA, Artim SC, Yaffe MB. 2005. A structural basis for 14-3-3σ functional specificity. J Biol Chem 280:18891–18898. doi:10.1074/jbc.M500982200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500982200</ArticleId><ArticleId IdType="pubmed">15731107</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, Wang J, Cong Q, Kinch LN, Schaeffer RD, Millán C, Park H, Adams C, Glassman CR, DeGiovanni A, Pereira JH, Rodrigues AV, van Dijk AA, Ebrecht AC, Opperman DJ, Sagmeister T, Buhlheller C, Pavkov-Keller T, Rathinaswamy MK, Dalwadi U, Yip CK, Burke JE, Garcia KC, Grishin NV, Adams PD, Read RJ, Baker D. 2021. Accurate prediction of protein structures and interactions using a three-track neural network. Science 373:871–876. doi:10.1126/science.abj8754</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8754</ArticleId><ArticleId IdType="pmc">PMC7612213</ArticleId><ArticleId IdType="pubmed">34282049</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171–176. doi:10.1016/j.virol.2009.06.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.06.045</ArticleId><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, Emdad L, Bhoopathi P, Fisher PB, Lloyd RE, van Kuppeveld FJM. 2014. Enterovirus 2A pro targets MDA5 and MAVS in infected cells. J Virol 88:3369–3378. doi:10.1128/JVI.02712-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong AB, Masters SC, Yang H, Fu H. 2002. Role of the 14-3-3 C-terminal loop in ligand interaction. Proteins 49:321–325. doi:10.1002/prot.10210</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.10210</ArticleId><ArticleId IdType="pubmed">12360521</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M, Kapell S, Hertz NT, Wu X, Bell K, Ashbrook AW, Mark MT, Zebroski HA, Neal ML, Flodström-Tullberg M, MacDonald MR, Aitchison JD, Molina H, Rice CM. 2020. Defining the proteolytic landscape during enterovirus infection. PLoS Pathog 16:e1008927. doi:10.1371/journal.ppat.1008927</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008927</ArticleId><ArticleId IdType="pmc">PMC7549765</ArticleId><ArticleId IdType="pubmed">32997711</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>